Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CELG - NantKwest: Continues To Sell Off Despite The Clinical Progress


CELG - NantKwest: Continues To Sell Off Despite The Clinical Progress

My plan for my investment in NantKwest (NK) was to build a conservative position in anticipation that the market will start to identify the prospective upside in the stock. Indeed, NantKwest still has a couple of years from a potential product launch. Still, I expect CEO and founder Dr. Soon-Shiong will continue to validate NK-92's safety and efficacy in some the worst oncology indications, which should force the market to recognize the company's pivotal role in the Nant Cancer Vaccine. Regrettably, a few months have passed since I started a position in NK,

Read more ...

Stock Information

Company Name: Celgene Corporation
Stock Symbol: CELG
Market: NASDAQ

Menu

CELG CELG Quote CELG Short CELG News CELG Articles CELG Message Board
Get CELG Alerts

News, Short Squeeze, Breakout and More Instantly...